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Proton translocationTranshydrogenase couples hydride transfer between NADH and NADP+ to proton translocation across a
membrane. The binding of Zn2+ to the enzyme was shown previously to inhibit steps associated with proton
transfer. Using Zn K-edge X-ray absorption ﬁne structure (XAFS), we report here on the local structure of Zn2+
bound to Escherichia coli transhydrogenase. Experiments were performed on wild-type enzyme and a mutant
in which βHis91 was replaced by Lys (βH91K). This well-conserved His residue, located in the membrane-
spanning domain of the protein, has been suggested to function in proton transfer, and to act as a ligand of the
inhibitory Zn2+. The XAFS analysis has identiﬁed a Zn2+-binding cluster formed by one Cys, two His, and one
Asp/Glu residue, arranged in a tetrahedral geometry. The structure of the site is consistentwith the notion that
Zn2+ inhibits proton translocation by competing with H+ binding to the His residues. The same cluster of
residues with very similar bond lengths best ﬁts the spectra of wild-type transhydrogenase and βH91K.
Evidently, βHis91 is not directly involved in Zn2+ binding. The locus of βHis91 and that of the Zn-binding site,
although both on (or close to) the proton-transfer pathway of transhydrogenase, are spatially separate.n).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Divalent metal ions, such as Zn2+ and Cd2+, inhibit the catalytic
cycle of a number of important membrane proteins, including the
cytochrome bc1 complex [1] cytochrome oxidase [2,3], and the
bacterial photosynthetic reaction center [4]. There is evidence that
in each case the metal ions block proton-transfer steps. In photosyn-
thetic reaction centers the metal-ion binding site was located at the
cytoplasmic surface of the protein by X-ray crystallography. The Zn2+-
ligand cluster is formed by the imidazole side chains of two His
residues, by the side chain of an Asp, and most likely by a water
molecule [5]. The tetrahedral coordination geometry was subse-
quently conﬁrmed by X-ray absorption ﬁne structure (XAFS), which
allowed a high-resolution determination of the bond lengths [6]. Cd2+
can also bind at this site but in an octahedral geometry by a cluster
which involves the same amino acid residues and possibly four water
molecules [7]. The X-ray crystallography and XAFS data provide
detailed structure information on the mechanism by which Zn2+ andCd2+ obstruct proton entry into the reaction center protein [4–7].
Biochemical studies indicate that a similar mechanism may be
relevant to metal-ion inhibition of other H+-translocating redox
complexes [1–3,8]. Structural information on the high-afﬁnity Zn2+-
binding sites of cytochrome bc1 complex [9,10] and of cytochrome c
oxidase [11,12] are consistent with the proposed inhibition mecha-
nism, and indicate that at least one His residue is always present in the
metal binding cluster.
Low concentrations of Zn2+, Cd2+ and other metal ions were
recently shown to inhibit speciﬁc catalytic steps in transhydrogenase
[13,14]. This enzyme, found in the inner mitochondrial membrane of
animal cells and in the cytoplasmic membrane of many bacteria,
couples a redox reaction, hydride transfer betweenNAD(H) and NADP
(H), to proton translocation:
NADHþ NADPþ þ Hþout↔NADþ þ NADPH þ Hþin ð1Þ
where H+out and H+in denote hydrogen ions outside and inside the
intact coupling membrane system (Fig. 1, and for review see [15,16]).
Transhydrogenase has three structural components: dI, which binds
NAD+ and NADH, and dIII, which binds NADP+ and NADPH, both
protrude from the membrane (towards the matrix in mitochondria,
Fig. 1. Inhibition by Zn2+ of proton transfer through transhydrogenase. Inside and
outside refer to the aqueous phases on either side of the intact membrane. The reaction
is shown as proceeding in the “forward” direction. The ladder of short horizontal lines
represents the transmission of a conformational change from the proton-transfer
pathway to the nucleotide-binding and hydride-transfer site. βHis91 is located in the
putative transmembrane helix 9 in dII [25].
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resolution crystallographic structures are available for dI [17,18], dIII
[19,20] and dI–dIII complexes [21], but not for dII.
In membrane vesicles from Escherichia coli and Rhodospirillum
rubrum, Zn2+ inhibits forward and reverse transhydrogenation (see
Eq. (1)) but, depending on pH, has either no effect on, or stimulates
“cyclic” transhydrogenation, a partial reaction in which NADP+ and
NADPH remain bound to the enzyme, and which is not coupled to
proton translocation across the membrane [13]. These differential
effects led to the conclusion that the metal ion interferes speciﬁcally
with proton-translocation steps associated with binding and release
of NADP+/NADPH. It was suggested that Zn2+ binds to a site in the
proton-transfer pathway, and blocks translocation, as in the photo-
synthetic reaction center. Consistent with this view, attenuated total-
reﬂectance Fourier-transform infrared (ATR-FTIR) difference spec-
troscopy indicated that His and Asp/Glu residues are involved in the
Zn2+-binding cluster [14].
βHis91, a residue well-conserved across species and located in the
membrane-spanning domain of transhydrogenase (see Fig. 1), was
proposed to play an important role in the enzyme's turnover, possibly
participating in proton translocation [14,22–26]. A mutant in which
βHis91 was replaced by Lys exhibited greatly reduced forward and
reverse transhydrogenation and stimulated the cyclic reaction, thus
mimicking the effects of Zn2+ treatment of the wild-type enzyme
[14,23,25,26]. Zn2+-induced ATR-FTIR difference spectra of the
βH91K mutant also revealed contributions from His and carboxylate
residues, but the signal amplitudes were signiﬁcantly lower than
those in wild-type enzyme, particularly in the spectral region at-
tributable to His [14]. These observations led to the suggestion that
Zn2+ binding and the βHis91→Lys substitution inhibit proton trans-
location at the same or neighbouring sites, and that the imidazole side
chain of βH91 might provide a ligand for the metal ion.
X-ray absorption ﬁne structure (XAFS) is a useful tool for probing
the local structure of a metal ion in a protein since it can be applied to
non crystalline samples and can provide structural information at
subatomic resolution (<0.2 Å) (eg [27]). In this communication
we present an XAFS analysis of Zn2+-binding sites in puriﬁed
transhydrogenase complexes from E. coli. In order to test the possible
involvement of βHis91 in coordinating the metal, we have analyzed
XAFS spectra acquiredwith thewild-type enzyme andwith theβH91K
mutant. A single Zn2+-binding cluster formed by one Cys, two His andone Asp/Glu residue, arranged in the same tetrahedral coordination
geometry, best accounts for theXAFS spectra of both thewild-type and
themutant transhydrogenase, indicating that βHis91 does not directly
participate in the binding site.
2. Materials and methods
2.1. Sample preparation
Wild-type E. coli transhydrogenase and its βH91K mutant, each
carrying a cleavable His tag at the N-terminus of the α subunit, were
expressed from pSI4 and pSI5, respectively, and puriﬁed by Ni2+
chromatography, as described [14]. Precautions were taken to limit
contamination of the protein by metal ions in the buffer solutions, as
indicated in the earlier report. The tag was removed from both
proteins with Factor Xa, and the transhydrogenases were separated
from the cleavage enzyme and products by gel permeation chroma-
tography [14]. Protein quantities were determined using the
bicinchoninic acid assay [28], and are given below in mol of “dI–dII–
dIII monomer”. The proteins were stored in 50 mM HEPES-KOH, pH
7.5, 0.2 M NaCl, 0.05% Anapoe35, 25% w/v glycerol at −20 °C, as
described [14]. Following storage the proteins (0.10 µmol wild-type
protein in 20 mL of storage buffer, and 0.11 µmol βH91K in 15 mL)
were dialysed against 50 mM HEPES-KOH, pH 8.2, 2 mM MgCl2 0.05%
Anapoe35. The two proteins were concentrated to a volume of approx
1.5 mL using Vivascience 100 k cut-off ﬁlters, and then further
dialysed against similar buffer before concentrating to approx 0.6 mL.
The wild-type and mutant transhydrogenases were each mixed
with appropriate stock solutions to give 1.0 mL of 45 µM protein, 3.3%
w/v polyvinyl alcohol (PVA, Mr≈130,000, Fluka), 50 mM HEPES-
KOH, pH 8.2, 2 mM MgCl2, 0.05% Anapoe35. Separate 1.0 mL samples,
identical to these but for the presence of 36 µM added ZnCl2, were also
prepared. The four solutions were each transferred to 3×3×0.3 cm3
Teﬂon holders, and dehydrated under dry nitrogen ﬂow, incurring a
volume decrease of about 10 fold. The incorporation of membrane
complexes at high concentration into PVA ﬁlms yields samples that
are stable and easy to handle [6,10].
Thermolysin (TLS) and superoxide dismutase (SOD) from bovine
erythrocytes were purchased from Calbiochem and Sigma-Aldrich,
respectively. TLS was re-crystallized as described in [29]. Films were
prepared by adding 350 µl of a 10% w/v solution of PVA to 1 mL of
20 mMCa-acetate, pH 7.5 containing 15 mg TLS and to 1 mL of 50 mM
Tris–HCl, pH 7.5 containing 3 mg SOD. The solutions were dehydrated
under nitrogen as described above.
2.2. Transhydrogenation assay
Rates of reverse transhydrogenation by the puriﬁed, detagged
protein were measured by recording the reduction of acetyl pyridine
adenine dinucleotide (AcPdAD+, 200 µM) by NADPH (200 µM) in
50 mM HEPES, pH 7.2, 2 mM MgCl2, 0.01% Anapoe35 (see [14]). Rates
of cyclic transhydrogenation were measured from the reduction of
AcPdAD+ (200 µM) by NADH (200 µM) in the presence of NADP+
(50 µM) in the same buffer. The reaction rates were similar to those
measured under similar conditions in previous work [14].
2.3. XAFS data collection and analysis
Experimental Zn K-edge spectra of the protein ﬁlms were collected
at beamline GILDA-BM08 [30] of the European Synchrotron Radiation
Facility. A Si(311) double crystal monochromator employing dynam-
ical sagittal focussing [31] was used. The spot size was approximately
1×1 mm2 and the ﬂux on the sample 3×1010photons s−1. Data were
collected at 80 K, using a 13-element hyper-pureGe detector equipped
with fast digital electronics and a peaking time of 1 µs [32]. The total
Fig. 2. Experimental XANES spectra. K-edge Zn XANES spectra for wild-type
transhydrogenase without and with added Zn2+ (WT and WT-Zn, respectively), for
its βH91K mutant without and with added Zn2+ (BH91K and BH91K-Zn, respectively),
and for a reference sample obtained by embedding ZnCl2 in a PVA matrix (Zn-PVA). All
spectra were measured at 80 K.
Fig. 3. The experimental EXAFS spectra and their ﬁts based on the 1Cys 2His 1Asp/Glu
model. Zn K-edge EXAFS spectra for wild-type transhydrogenase without and with
added Zn2+ (WT andWT-Zn, respectively), and for its βH91Kmutant without and with
added Zn2+ (BH91K and BH91K-Zn, respectively), measured at 80 K (circles). For each
spectrum the continuous line shows the corresponding k-space best ﬁt. Dashed lines
indicate the ﬁtting range 2.5–12.5 Å−1.
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and 90 s/point for samples without added Zn.
In order to check for possible modiﬁcations in the local structure of
the Zn site caused by irradiation during the measurement, we com-
pared 5 consecutive spectra that had been acquired on the same
position of samples containing the wild-type transhydrogenase and
its βH91K mutant. In each case, the ﬁrst XANES spectrum, which
required an acquisition time of 20min, was indistinguishable from the
spectra acquired subsequently; this suggests that radiation damage
was not signiﬁcant. Similarly, no changes were detected in consec-
utive spectra in the EXAFS region, even after an exposure of 8h.
EXAFS spectra were extracted from the raw data using the Autobk
algorithm [33] implemented in the Athena package [34], and then
ﬁtted with Artemis 0.8.013 [34]. Theoretical scattering amplitudes
and phase shifts were calculated by means of the ab initio code
FEFF8.2 [35], including Self Consistent Field calculations for the
potential in a radius of 4.8 Å around the absorber. All of the multiple
scattering signals arising from up to ﬁve single scattering events
relative to the same amino acid and with an effective length ≤5 Å
were taken into account in the ﬁtting procedure. The amplitude
reduction factor S02 was calculated from atomic overlap integrals by
the program: its value was ﬁxed to 0.95 during the analysis.
Input clusters for FEFF8.2 were built using MOLDRAW [36] for
visualization and manipulation, setting ﬁrst neighbour distances to
the target values provided by M. M. Harding (see [37] and references
therein) and interatomic distances and angles relative to each amino
acid to the values provided by Engh and Huber [38]. Initial Debye
Waller (DW) factors values were derived from the parameterization
provided by Dimakis and Bunker as a result of Density Functional
Theory calculations [39]. Fits were performed directly in k space, with











where X̃i are the values of the EXAFS function, and N is the total
number of experimental points. The Rigid Body Reﬁnement scheme
was applied [40].
Simulations of XANES spectra were performed using the Finite
Difference Method implemented in the FDMNES program [41].
3. Results
PVA ﬁlms of intact, puriﬁed, detergent-dispersed transhydrogenase
from E. coli were prepared in the absence and presence of ZnCl2. From
titrations of the inhibitory effect of Zn2+ on the rate of reverse
transhydrogenation the Kd for the metal ion is 2.5 µM at pH 8.2 [14].
Assuming for the moment that there is only one metal-ion binding site
per protein monomer then, in the solutions used to prepare the ﬁlms
(45 µM protein, 36 µM ZnCl2), 68% of the Zn2+ sites would be occupied
and the concentration of free Zn2+ (or Zn2+ bound towater molecules)
would be 5.4 µM. During dehydration of the ﬁlm the volume reduction
will have led to an increase in binding, and a corresponding decrease in
the amount of free Zn2+. This should ensure that the contribution of free
metal ion to the XAFS spectra is negligible (and see below).
XAFS spectra were acquired in ﬁlms containing wild-type transhy-
drogenase and its βH91K mutant in the absence (samples designated
WT and BH91K, respectively) and presence of added Zn ions (WT-Zn
and BH91K-Zn, respectively) — Figs. 2 and 3. There was much lower
but nevertheless signiﬁcant Zn Kα ﬂuorescence in the two samples
prepared without added Zn2+ indicating a low level of contaminating
metal ion in both the wild-type and βH91K proteins. Because the ﬁlm
thickness was not homogeneous, and because ﬂuorescence is strongly
affected by experimental geometry, these data cannot be used to
evaluate accurately the amount of contaminating Zn2+. We thereforeused a functional assay of the puriﬁed protein in solution to show that
the amount of the bound metal ion is indeed very low. Firstly, we
conﬁrmed that the inhibitory effect of added Zn2+ (50 µM) on reverse
transhydrogenase, and the stimulatory effect of themetal ion on cyclic
transhydrogenation, were relieved (by 85%) upon subsequent addi-
tion of 200 µM EDTA [13,14]. This shows that the EDTA effectively
removes Zn2+ from the inhibitory site on the enzyme. Then in
duplicate samples of puriﬁed transhydrogenase in the absence of
added Zn2+,we found that 200 µMEDTAneither stimulated the rate of
reverse transhydrogenation nor inhibited the rate of the cyclic
reaction. This shows that the amount of contaminating Zn2+ bound
to the transhydrogenaseunder assay conditions is less than the error in
the rate measurements (approx 5%, see [14]).
The near-edge regions of the spectra (XANES, Fig. 2) and the EXAFS
functions (Fig. 3) were very similar for all four samples indicating just a
single class of Zn2+-binding sites. Evidently the sites are similar in the
Fig. 4. Experimental Fourier Transformed EXAFS spectra of model proteins and wild-
type transhydrogenase, and its ﬁrst-shell ﬁt. The Fourier Transformed K-edge Zn
spectra of wild-type transhydrogenase with added Zn2+ (open circles), superoxide
dismutase (ﬁlled squares), and of thermolysin (ﬁlled circles), embedded in PVA ﬁlms,
are shown. The spectra were collected at 80 K and transformed in the k range 2.5–
12.5 Å−1. The continuous line shows the ﬁrst-shell ﬁt for the transhydrogenase
spectrum; the ﬁtting range 1–2.2 Å is indicated by the dashed lines.
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inating Zn2+ populates a small fraction of the sites occupied by the
addedmetal ion. In Fig. 2we also show theXANES spectrumof a sample
madeof ZnCl2 embedded in PVA in the absence of protein (Zn-PVA). The
higher white-line intensity and the lack of inﬂection points after the
white line and up to 9675 eV make this markedly different from the
XANES spectra of the transhydrogenase samples. This difference
indicates that there is no signiﬁcant contribution from PVA-bound Zn
in the spectra of the transhydrogenase samples. It suggests that
essentially all the metal ions detected by XAS in the transhydrogenase
samples are bound to the protein and that contributions from unbound
ions dispersed in the PVA matrix are negligible.
Information on the coordination number of Zn2+ in the transhy-
drogenase samples can be obtained by comparing the observed
XANES spectra with those simulated using the commonest high-
resolution structures in the Protein Data Bank with 4-, 5-, and 6-
coordinated Zn sites [42]. Consistent with experimental data [43],
simulations of XANES spectra show that the white-line intensity
increased with the coordination number. In particular we observed
that the maximum of the simulated absorption coefﬁcient was never
higher than 1.5 when Zn occupies a tetrahedral site, in agreement
with [43]. A white-line intensity lower than 1.6 was never observed
for coordination numbers of 5 and 6. In all the transhydrogenase
samples examined the maximum absorption coefﬁcient was lower
than 1.5, indicating that the Zn2+ is 4-coordinated.
The relative number of S atoms and N/O atoms in the Zn coor-
dination sphere can be determined by an R-space ﬁrst-shell ﬁt. In our
calculations the number of S atoms, n, was a free parameter of the ﬁt,
while the total number of Zn neighbours was set to 4. The remaining
(4−n) atoms could be either N or O; we did not try to distinguish
between these low atomic number ligands at this stage of the analysis,
since their contributions to the ﬁrst-shell signal are very similar and
easily mistaken [44]. Zn–S and Zn–N/O distances were also free
variables of the ﬁt and their convergence to reasonable values was
checked. The fourth and last free parameter in these ﬁts was a com-
mon shift in the energy origin (ΔE0) of the included scattering paths.
In our analysis DW factors were ﬁxed to values calculated from the
parameterization provided in [39]. The Fourier transformed (FT)
EXAFS spectrum forWT-Zn is shown in Fig. 4 (empty circles), together
with its ﬁrst-shell ﬁt performed in the R region, 1.0–2.2 Å (continuous
line). According to the ﬁt results, indicating the presence of 0.9±0.1 S
atoms, and consequently 3.1±0.1 N/O, we expect Zn2+ to bind 1 Cys
and 3more ligands to be identiﬁedmost probably fromHis, carboxylic
acids and water molecules [45]. We propose that the S atom can
indeed be assigned to a Cys residue on the basis of a Metalloprotein
Database and Browser (MDB) search (http://metallo.scripps.edu/):
where S atoms provide a ligand for Zn2+, they are always located in
Cys residues, never Met.
The imidazole ring of His is the only structure amongst possible
Zn2+ ligands which can contribute signiﬁcantly to the Multiple Scat-
tering paths responsible for the signal at high R values [46]. Therefore,
an inspection of the 3–4 Å region of the FT spectrum can provide
information on the number of His residues present in the cluster. We
compared the transhydrogenase FT spectrum with those of reference
samples recorded in similar experimental conditions, and in which
the number of His residues per Zn2+ cluster is known. The chosen
reference proteins were Thermolysin (TLS) and Superoxide Dismu-
tase (SOD). As shown by X-ray crystallography, and conﬁrmed by
XAFS analysis, TLS binds a Zn ion, coordinated by 2 His, 1Glu and 1
water molecule [47], while the Zn ion bound to SOD is coordinated by
3 His and 1 Asp [48]. The FT spectra reported in Fig. 4 clearly show that
the amplitude of theMS contribution in the 3–4 Å region of theWT-Zn
transhydrogenase spectrum is comparable to that of TLS. Measuring
the amplitude of these contributions by numerical integration in the
region 3–4 Å we obtain a value of 1.20 for the WT-Zn spectrum, very
close to the value of 1.29 calculated for TLS and markedly differentfrom the value of 1.85 obtained for SOD.We can therefore assume that
Zn2+ in theWT-Zn sample is bonded to 2 His residues, like the Zn2+ of
TLS. The fourth ligand could be either a carboxylic acid residue or a
watermolecule, but since ATR-FTIR experiments indicated a change in
the vibrational modes of Asp/Glu residues upon Zn2+ binding [14],
it is reasonable to assume the presence of an Asp/Glu in the Zn2+
coordination shell.
We therefore chose a 1Cys 2His 1Asp/Glu coordination shell as a
starting model. In order to minimize the correlation between the
ﬁtting parameters, the ﬁt to the EXAFS function in k space was
performed in a step-by-step procedure [49]. In step (1) the free
parameters of the ﬁt were three ﬁrst-shell distances (one for each
different amino acid residue), and the bending angle of Asp/Glu,
while the DW factors were ﬁxed. In step (2) ﬁrst-shell distances were
ﬁxed to the best-ﬁt values of the previous ﬁtting step and the DW
factors were allowed to vary: the free parameters of the ﬁt were then
ﬁrst-shell Single Scattering (SS) DWs and a common value, σ2MS, for
all of the Multiple Scattering (MS) paths. In step (3) DWs were set to
the best-ﬁt values of step (2) and ﬁrst-shell distances were allowed to
vary. When ﬁtting the EXAFS spectra measured in the experimental
samples the distances obtained in step (3) always converged to values
that were in close agreement with those found in step (1), proving the
robustness of the ﬁtting procedure. In all ﬁtting steps a shift in the
energy origin (ΔE0) was included as a free parameter.
The ﬁtting model was chosen and tested on the WT-Zn data, and
then extended to that from the other experiments. The ﬁts for all four
samples are shown in Fig. 3 as continuous lines. The agreement
between the ﬁtting curve and the experimental signal is good,
particularly in the WT-Zn and BH91K-Zn samples, where the signal-
to-noise ratio (S/N) is higher as a consequence of the higher Zn
ﬂuorescence counts. The slight inaccuracy in reproducing the high-
frequency oscillation at 4 Å−1 is related to multiple scattering
contributions. It probably arises because intra-ligand paths were not
included in the model. The best-ﬁt ﬁrst-shell distances (i.e. the output
of step 3 of the ﬁtting procedure) relative to the model, 1Cys 2His
1Asp/Glu, are reported in Table 1. The corresponding DW factors (i.e.
the output of step 2) are given in Table 2. First-shell distances are the
same within the error in all samples except in BH91K, which has a
slightly shorter ﬁrst-shell average distance. The fact that the same
Table 1
Best-ﬁt ﬁrst-shell distances. First-shell distances were obtained by ﬁtting the EXAFS
spectra of the four samples to the 1Cys 2His 1Asp/Glu model described in the text. The
parameter α is the angle Zn-Oδ1-Cγ or Zn-Oε1-Cδ of the Asp/Glu residue, respectively,
and whose starting value is set to 105°. A common distance for Zn-Nε2 has been
assigned to the two His residues, and this therefore indicates the average of the two
actual distances. The values in brackets are the 1σ errors.
ΔE0 (eV) Zn–S (Å) Zn–Nε2 (Å) Zn–Oδ1/ε1 (Å) α (°) Rfactor
(%)
WT −2.7 (1.3) 2.288 (0.013) 2.016 (0.016) 1.972 (0.025) 112 (3) 7.2
WT-Zn −2.4 (1.0) 2.290 (0.009) 2.018 (0.014) 1.969 (0.015) 114 (2) 6.1
BH91K −4.6 (1.5) 2.268 (0.011) 1.976 (0.013) 1.99 (0.03) 106 (1) 7.3
BH91K-Zn −2.0 (0.8) 2.287 (0.007) 2.018 (0.010) 1.968 (0.015) 113 (2) 4.8
Fig. 5. The EXAFS spectrum of Zn in the βH91K mutant of transhydrogenase ﬁtted with
two different models. Upper panel: the experimental Zn K-edge EXAFS spectrum of the
BH91K-Zn sample (open circles) and its k-space ﬁts (continuous lines) based on the
1Cys 1His 1Lys 1Asp/Glu model (indicated by the tag LYS), and the 1Cys 2His 1Asp/Glu
model (indicated by HIS). Lower panel: Fourier Transforms of the experimental spectra
(black dots) and of the ﬁts (continuous lines) shown in the upper panel.
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BH91K-Zn, conﬁrms that the contaminating Zn2+ in the samples with
no exogenous metal ion populates a fraction of the same site resolved
in the presence of added Zn2+.
Since the same cluster of residues nicely ﬁts the signals measured
in samples containing the native and the mutant transhydrogenase,
we are led to think that the Zn2+-binding site is indeed the same, i.e.
that the mutated βHis91 is not involved in the binding cluster. If it
were, the spectrum of the BH91K-Zn sample would differ from that of
WT-Zn, and it would reveal a Lys residue instead of one of the His
ligands in the coordinating cluster. In order to test quantitatively this
possibility we have ﬁtted the BH91K-Zn spectrum with the model,
1Cys 1His 1Lys 1Asp/Glu. Fig. 5 compares the best ﬁt to the two
models. It clearly shows that the Lys-containing cluster gives a poorer
ﬁt to the spectrum. This is particularly evident when comparing the FT
signals (lower panel): the 1Cys 1His 1Lys 1Asp/Glu model (indicated
with LYS in the ﬁgure) gives a worse ﬁt to the experimental data than
the 1Cys 2His 1Asp/Glu model (indicated with HIS), both in the ﬁrst
shell and in the 3–4 Å region where the His contributions are
predominant. In fact, the R factor of the ﬁt increases from 4.8% to
7.1% when a His is replaced with a Lys. The inadequacy of the LYS
model is further illustrated by the best-ﬁt value found for the DW
factor common to all MS paths, i.e. σ2MS=0.000±0.002 Å2. The DW
factors and the amplitude reduction factor S02 are correlated ﬁt
parameters; the value of S02=0.95 was calculated and then ﬁxed
during the analysis— this could affect the resulting values of the DWs.
Although a value of 0.95 is quite reasonable for S02, we have tested the
effect of varying this value on the DW factors. Thus, we ﬁtted the
BH91K-Zn spectrum to the 1Cys 1His 1Lys 1Asp/Glu model setting S02
to 0.8, a lower but still reasonable value. This procedure led again to
the best-ﬁt value σ2MS=0.000±0.002 Å2, but to a worse ﬁt, as
indicated by the R factor of 8.6%. The result of a null multiple
scattering DW factor, independent of the choice of the S02 value, would
lack physical meaning. It would indicate that the MS contributions
relative to the LYS model are too weak to reproduce the experimental
spectrum, and that they could ﬁt only if they were not damped (i.e.
associated to a null Debye Waller factor).
The differences in the R factors and in the reduced chi squared
values (53±16 and 130±40, respectively, for the HIS and LYSTable 2
Best-ﬁt Debye Waller factors. First-shell Single Scattering Debye Waller factors and a
Multiple Scattering DW common to all MS paths, as determined by ﬁtting the four
EXAFS spectra with the 1Cys 2His 1Asp/Glu model. The subscripts relative to Nε2 of His











WT 3.9 (1.0) 3.5 (2.5) 5 (5) 7.6 (2.2) 7.2
WT-Zn 3.1 (0.7) 4 (3) 2 (4) 4.4 (1.1) 6.2
BH91K 2.3 (0.8) 3.1 (1.4) 4.0 (2.0) 6.9 (2.5) 7.2
BH91K-Zn 2.3 (0.6) 2.9 (1.4) 3.6 (2.3) 4.5 (1.0) 4.8models) are at the limit of resolution from a statistical point of view
(see [10] and references therein). However, all the evidence reported
above strongly supports the idea that the Zn2+-binding site does not
involve a Lys residue. Moreover, if one of the two His residues present
in the Zn2+-binding motif of wild-type transhydrogenase were re-
placed by another ligand in the mutant, we would encounter
differences in the XANES regions of the spectra. However, these
regions are nearly identical to one another (Fig. 2). Finally, wemust in
principle consider also the possibility that in the βH91K mutant Zn2+
loses one of its ligands and results in a coordination number of 3. In
fact, if βHis91 were one of the Zn2+ ligands in the wild-type protein,
its substitutionwith a Lys would introduce a positively charged amino
acid into the coordination sphere, which would clearly have a lower
propensity to bind Zn2+. This possibility can however be excluded
because a decrease in the coordination number would cause a
signiﬁcant decrease in the EXAFS oscillation amplitude and in the
XANES white-line intensity which we do not observe at all in the
BH91K spectra. In conclusion, XANES and EXAFS analysis identiﬁes the
same Zn2+-binding cluster, formed by 1Cys, 2His, and 1Asp/Glu
residue in the native transhydrogenase and in its βH91K mutant (see
Fig. 6). This strongly argues against an involvement of βHis91 in the
Zn2+-binding site that is detected by XAFS.
4. Discussion
The Zn K-edge XAS spectra of puriﬁed E. coli transhydrogenase
described above were interpreted in terms of a single Zn2+-binding
site. The existence of two (or more) sites with different structures and
binding afﬁnities is unlikely: it would contradict the ﬁnding that
spectra obtained with low levels of contaminating Zn2+ have very
similar features to those obtained with much higher concentrations of
the metal ion. Thus, even small differences in binding afﬁnity would
lead to signiﬁcant changes in the relative site occupation, towhich XAS
is rather sensitive. The existence of two structurally different siteswith
identical Zn2+-binding afﬁnities is not ruled out by these observations
butwould be difﬁcult to reconcilewith the internal consistencies of the
XAS analysis, notably the convergence of results from different ﬁtting
procedures. It is likely therefore that there is indeed only a single site in
Fig. 6. The proposed Zn2+-binding cluster. Wireframe structure of the Zn2+-binding
cluster which gives the best ﬁt of the experimental XAFS data obtained for both the
wild-type transhydrogenase and its βH91K mutant.
499G. Veronesi et al. / Biochimica et Biophysica Acta 1797 (2010) 494–500transhydrogenase that binds Zn2+ in the concentration range of our
experiments; the XAS experiments indicate that the site is a
tetrahedral cluster formed by the imidazole rings of two His residues,
and the side chains of a Cys and an Asp/Glu. We propose that Zn2+
inhibition of proton translocation by transhydrogenase [13,14] is a
consequence of the metal ion binding to this site. In the absence of
metal ions, one or more of the amino acid residues in the cluster may
be involved in proton transfer, and Zn2+ would inhibit by competing
with H+ binding to the site. The inhibitory Zn2+-binding sites in
reaction centers of Rhodobacter sphaeroides [5,6], and in avian and
bovine cytochrome bc1 complexes [10] also have twoHis and one Asp/
Glu residues, and these sites too are thought to be involved in proton
transfer and to bind the metal ion competitively.
Mutation of βHis91 to Lys was found to have somewhat similar
effects on transhydrogenase reactions to treatment of the enzyme
with Zn2+ [14]. An analysis of these effects led to the conclusion that
both the amino acid substitution, and metal-ion binding, interfere
with proton translocation. In other experiments the addition of Zn2+
to wild-type transhydrogenase led to changes in the ATR-FTIR dif-
ference spectrum that were attributable to effects on His and Asp/Glu
residues in the protein [14]. In the βH91Kmutant the amplitude of the
signals due to Asp/Glu, and particularly those due to His, in the Zn2+-
induced difference spectrumwas decreased prompting the suggestion
that βHis91 in wild-type transhydrogenase might be a ligand for the
Zn2+. However, in the present study we found that the Zn XANES and
EXAFS spectra were very similar in the wild-type and in the βH91K
mutant. The same binding cluster of 1Cys, 2His and 1Asp/Glu residue
provides the best ﬁt for both sets of data. An alternative model, a 1Cys,
1His, 1Lys, and 1Asp/Glu Zn2+-binding cluster, yielded a worse ﬁt to
the measured spectra of the mutant protein. The inadequacy of the
“mutated” cluster was particularly evident in the spectral region
dominated by the His contributions. It is very unlikely that βHis91
participates directly in Zn2+-binding.
The Zn2+-binding site in dII is on the inside of the intact mem-
brane (the n-side) [14] — see Fig. 1. Although there is currently no
high-resolution structure of the membrane-spanning dII component
of transhydrogenase, hydropathy proﬁles and biochemical experi-
ments have led to a topology model of the E. coli enzyme [50]. If we
assume that amino acid residues in the site are located close to the
interface between the inside aqueous phase and the membranedielectric, and we allow for some uncertainty in the position of the
transmembrane helices in the model, then the side chains of Cys397,
Cys435, His447, and His450 in theα subunit, and His27, Glu28, Glu79,
Glu82, Glu85, Cys147, His204, Asp213 and Cys260 in the β subunit are
candidates for the Zn2+-binding ligands.
It seems that, although βHis91 and the Zn2+-sensitive site both
function in the proton-translocation pathway of transhydrogenase,
they are spatially separate. Indeed, it was noted [14] that the low
residual rate of reverse transhydrogenation in βH91K was further
inhibited by Zn2+, and that the elevated rate of cyclic transhydro-
genation in the mutant was further stimulated by metal ions. To
reconcile the present XAFS results with the effects of the βHis91→Lys
mutation on the Zn2+-induced FTIR difference spectra [14] we
propose the following. The binding of Zn2+ to a site in transhydro-
genase dII formed by 1Cys 2His and 1Asp/Glu, causes structural
changes that are transmitted to the somewhat more distant βHis91
residue. The FTIR difference spectra detect these changes in βHis91 as
well as those arising from one or both of the His residues which form
the binding site. When βHis91 is mutated into a Lys, Zn2+ binding still
perturbs the vibrational bands of the His residue(s) that act as ligand
(s), but the absence of the contribution from βHis91 causes the
observed decrease in the overall His FTIR signal.
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